<p>, /PRNewswire/ -- 根據 MarketsandMarkets™的報告，<strong>血液學分析儀和試劑市場</strong> 預計將從 2026 年的約 75.7 億美元增長到 2031 年的 103.3 億美元，年均增長率為 6.4%。</p>
<p><strong>瀏覽 250 個市場數據表和 59 個圖表，涵蓋 300 頁的詳細目錄，主題為'血液學分析儀和試劑市場 - 全球預測到 2031 年'</strong></p>
<p><strong>血液學分析儀和試劑市場規模及預測：</strong></p>
<ul>
<li><strong>可用市場規模年份：</strong> 2025–2031</li>
<li><strong>2026 年市場規模：</strong> 75.7 億美元</li>
<li><strong>2031 年預計市場規模：</strong> 103.3 億美元</li>
<li><strong>年均增長率（2026–2031）：</strong> 6.4%</li>
</ul>
<p><strong>血液學分析儀和試劑市場趨勢與洞察：</strong></p>
<ul>
<li>血液學分析儀和試劑細分市場預計在 2025 年將佔據最高市場份額，達到 60.5%。</li>
<li>中檔血液學分析儀細分市場預計將註冊最高的年均增長率，達到 6.3%。</li>
<li>血液癌症細分市場預計將在 2025 年佔據 34% 的收入份額，主導市場。</li>
<li>亞太地區預計將在全球血液學分析儀和試劑市場中見證最高的年均增長率，達到 7.7%。</li>
</ul>
<p><strong>下載 PDF 手冊 @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
<p>由於傳統 CBC 測試的侷限性，越來越多的趨勢是使用先進的儀器和方法來診斷與血液相關的疾病，包括血液惡性腫瘤。與傳統方法不同，這種創新技術不僅評估血細胞的基本特徵，還評估其複雜特性，如形態。因此，可以更深入地瞭解血細胞羣體的整體狀況，包括識別異常細胞羣體。</p>
<p><strong>血液產品和服務細分市場預計將在 2026–2031 年的預測期內註冊顯著的增長率。</strong></p>
<p>根據產品和服務，血液產品和服務細分市場預計將在 2025–2031 年的預測期內註冊顯著的增長率。血液學分析儀和試劑產品市場細分為血液產品和服務、免疫血液學產品和服務，以及止血產品和服務。</p>
<p>每個產品和服務細分市場進一步包括儀器、試劑、耗材和服務。推動血液產品和服務細分市場在預測期內增長的主要因素包括實驗室自動化偏好的增加，如基於軌道的系統、中間件功能和自動驗證，這些都提高了生產力並縮短了週轉時間。此外，試劑和耗材的持續採購、由於血液相關疾病的流行而增加的測試數量，以及基於人工智能的決策系統的引入都在推動市場增長。</p>
<p><strong>請求樣本頁面 @</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
<p><strong>血液癌症細分市場預計將在預測期內佔據血液學分析儀和試劑的最大份額。</strong></p>
<p>在應用細分市場中，血液癌症目前主導血液學分析儀和試劑市場，因為高度依賴常規的高精度血液測試。白血病、淋巴瘤、骨髓瘤和其他血液腫瘤需要定期測量細胞計數和分類，以及評估異常細胞，從而導致持續的高測試數量。早期診斷和疾病監測在很大程度上也依賴於更復雜的血液學測試技術和參數。全球血液癌症的發病率不斷上升將進一步鞏固其在市場中的地位。</p>
<p><strong>亞太地區預計將在預測期內註冊市場最高的年均增長率。</strong></p>
<p>在 2025 年，亞太地區預計將在血液學分析儀和試劑市場中註冊最高的年均增長率。亞太地區包括中國、印度、韓國、台灣和新加坡，以及亞太地區的其他國家。傳染病和慢性疾病的發生率增加，加上患者數量的增長，將推動對診斷測試的需求。其他可能促進市場增長的重要因素包括健康服務的可用性增加、私營診斷實驗室的增長、使用高效和經濟的分析儀，以及對早期疾病檢測的認識提高。此外，技術的進步，如適用於資源有限環境的便攜式和即時檢測（POC）血液學分析儀，將進一步推動市場增長。</p>
<p><strong>購買前諮詢 @</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
<p><strong>血液學分析儀和試劑市場的頂級公司：</strong></p>
<p>血液學分析儀和試劑市場的頂級公司包括 Sysmex Corporation（日本）、Danaher Corporation（美國）、Nihon Kohden Corporation（日本）、Siemens Healthineers（德國）、Abbott Laboratories（美國）、Boule Diagnostics AB（瑞典）、Horiba, Ltd.（日本）、Bio-Rad Laboratories Inc.（美國）、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（中國）和 F. Hoffmann-La Roche Ltd.（瑞士）等。</p>
<p><strong>瀏覽相關市場</strong>：<strong>醫療設備市場研究</strong> <strong>報告與諮詢</strong></p>
<p><strong>相關報告：</strong></p>
<p><strong>體外診斷市場</strong> <strong>- 全球預測到 2030 年</strong></p>
<p><strong>即時檢測市場</strong> <strong>- 全球預測到 2029 年</strong></p>
<p><strong>凝血分析儀市場</strong> <strong>- 全球預測到 2030 年</strong></p>
<p><strong>臨牀化學分析儀市場</strong> <strong>- 全球預測到 2030 年</strong></p>
<p><strong>IVD 試劑市場</strong> <strong>- 全球預測到 2029 年</strong></p>
<p><strong>關於 MarketsandMarkets™</strong></p>
<p>MarketsandMarkets™被《福布斯》評選為美國最佳管理諮詢公司之一，依據其最新報告。</p>
<p>MarketsandMarkets™ 是增長諮詢和項目管理領域的藍海替代方案，利用人機結合的服務推動 B2B 領域進步組織的超常增長。我們以最廣泛的視角關注新興技術，擅長為全球客户共同創造超常增長。</p>
<p>如今，80% 的財富 2000 強公司依賴於 MarketsandMarkets，且每個行業前 100 家公司中有 90 家信任我們以加速其收入增長。我們擁有超過 13,000 家組織的全球客户羣，幫助企業在顛覆性生態系統中蓬勃發展。</p>
<p>B2B 經濟正在見證 25 萬億美元新收入來源的出現，這些收入將在本十年內取代現有的收入來源。我們與客户合作開展增長項目，幫助他們通過我們的服務線——市場總量擴展、市場進入（GTM）戰略到執行、市場份額提升、客户賦能和思想領導力營銷，來實現這一 25 萬億美元的機會。</p>
<p>基於 “GIVE Growth” 原則，我們與多家《福布斯》全球 2000 強 B2B 公司合作，幫助他們保持未來準備。我們的洞察和戰略由行業專家、尖端人工智能和我們的市場情報雲平台 KnowledgeStore™提供支持，整合研究並提供生態系統範圍內的收入變化可視化。</p>
<p>MarketsandMarkets™ SalesPlay 是一款基於人工智能的收入智能助手，旨在幫助收入團隊優先處理合適的客户，及早識別關鍵變化，並在需求之前發現機會，從而自然構建銷售管道，並以更高的一致性完成交易。</p>
<p>欲瞭解更多信息，請訪問 www.MarketsandMarkets™.com 或在 Twitter、LinkedIn 和 Facebook 上關注我們。</p>
<p>聯繫方式：</p>
<p>羅漢·薩爾加卡爾（Mr. Rohan Salgarkar）</p>
<p>MarketsandMarkets™ INC.</p>
<p>南國會大街 1615 號（1615 South Congress Ave.）</p>
<p>103 套房，德爾雷海灘，佛羅里達州 33445（Suite 103, Delray Beach, FL 33445）</p>
<p>美國電話：+1-888-600-6441</p>
<p>電子郵件：[email protected]</p>
<p>訪問我們的網站：https://www.marketsandmarkets.com/</p>
<p>標誌：https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
<p>來源 MarketsandMarkets</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw"/></p>

6869

希森美康(ADR)

丹納赫

<p>血液學分析儀和試劑市場預計將從 2026 年的 75.7 億美元增長到 2031 年的 103.3 億美元，年均增長率為 6.4%。亞太地區預計將見證最高的增長率，主要受對先進診斷工具需求增加和血液相關疾病發病率上升的推動。血癌細分市場預計將在 2025 年佔據市場主導地位，收入份額達到 34%。主要參與者包括希森美康（Sysmex Corporation）、丹納赫（Danaher Corporation）和西門子醫療（Siemens Healthineers）</p>

<p>, /PRNewswire/ -- According to MarketsandMarkets™, the <strong>Hematology Analyzers and Reagents Market</strong> is projected to grow from about USD 7.57 billion in 2026 to USD 10.33 billion by 2031, at a CAGR of 6.4%.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 根據 MarketsandMarkets™的報告，<strong>血液學分析儀和試劑市場</strong> 預計將從 2026 年的約 75.7 億美元增長到 2031 年的 103.3 億美元，年均增長率為 6.4%。</p>
</div><p><strong>Browse 250 market data Tables and 59 Figures spread through 300 Pages and in-depth TOC on 'Hematology Analyzers and Reagents Market - Global Forecast to 2031'</strong></p>
<div class="lb-trans"><p><strong>瀏覽 250 個市場數據表和 59 個圖表，涵蓋 300 頁的詳細目錄，主題為'血液學分析儀和試劑市場 - 全球預測到 2031 年'</strong></p>
</div><p><strong>Hematology Analyzers and Reagents Market Size &amp; Forecast:</strong></p>
<div class="lb-trans"><p><strong>血液學分析儀和試劑市場規模及預測：</strong></p>
</div><ul>
<li><strong>Market Size Available for Years:</strong> 2025–2031</li>
<li><strong>2026 Market Size:</strong> USD 7.57 billion</li>
<li><strong>2031 Projected Market Size:</strong> USD 10.33 billion</li>
<li><strong>CAGR (2026–2031):</strong> 6.4%</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>可用市場規模年份：</strong> 2025–2031</li>
<li><strong>2026 年市場規模：</strong> 75.7 億美元</li>
<li><strong>2031 年預計市場規模：</strong> 103.3 億美元</li>
<li><strong>年均增長率（2026–2031）：</strong> 6.4%</li>
</ul>
</div><p><strong>Hematology Analyzers and Reagents Market Trends &amp; Insights:</strong></p>
<div class="lb-trans"><p><strong>血液學分析儀和試劑市場趨勢與洞察：</strong></p>
</div><ul>
<li>The hematology analyzers &amp; reagents segment is estimated to account for the highest market share of 60.5% in 2025.</li>
<li>The mid-range hematology analyzers segment is expected to register the highest CAGR of 6.3%.</li>
<li>The blood cancer segment is expected to dominate the market with 34% revenue share in 2025.</li>
<li>The Asia Pacific region is projected to witness the highest CAGR of 7.7% in the global hematology analyzers &amp; reagents market.</li>
</ul>
<div class="lb-trans"><ul>
<li>血液學分析儀和試劑細分市場預計在 2025 年將佔據最高市場份額，達到 60.5%。</li>
<li>中檔血液學分析儀細分市場預計將註冊最高的年均增長率，達到 6.3%。</li>
<li>血液癌症細分市場預計將在 2025 年佔據 34% 的收入份額，主導市場。</li>
<li>亞太地區預計將在全球血液學分析儀和試劑市場中見證最高的年均增長率，達到 7.7%。</li>
</ul>
</div><p><strong>Download PDF Brochure @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>下載 PDF 手冊 @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
</div><p>There is an increasing trend toward using advanced instruments and methods to diagnose blood-associated disorders, including hematological malignancies, due to the limitations of the traditional CBC test. Unlike conventional approaches, this innovative technology evaluates not only the basic characteristics of blood cells but also their complex properties, such as morphology. As a result, deeper insight into the overall condition of blood cell populations is possible, including the identification of abnormal cell populations.</p>
<div class="lb-trans"><p>由於傳統 CBC 測試的侷限性，越來越多的趨勢是使用先進的儀器和方法來診斷與血液相關的疾病，包括血液惡性腫瘤。與傳統方法不同，這種創新技術不僅評估血細胞的基本特徵，還評估其複雜特性，如形態。因此，可以更深入地瞭解血細胞羣體的整體狀況，包括識別異常細胞羣體。</p>
</div><p><strong>The hematology products &amp; services segment is expected to register a significant growth rate over the forecast period of 2026–2031.</strong></p>
<div class="lb-trans"><p><strong>血液產品和服務細分市場預計將在 2026–2031 年的預測期內註冊顯著的增長率。</strong></p>
</div><p>Based on the product and service, the hematology products &amp; services segment is expected to register a significant growth rate over the forecast period of 2025–2031. The hematology analyzers and reagents product market is segmented into hematology products &amp; services, immunohematology products &amp; services, and hemostasis products &amp; services.</p>
<div class="lb-trans"><p>根據產品和服務，血液產品和服務細分市場預計將在 2025–2031 年的預測期內註冊顯著的增長率。血液學分析儀和試劑產品市場細分為血液產品和服務、免疫血液學產品和服務，以及止血產品和服務。</p>
</div><p>Each of the product &amp; service segments further comprises instruments, reagents, consumables, and services. The primary driving factors for the growth of the hematology products and services segment over the forecast period include the rise in automation preferences in laboratories, such as track-based systems, middleware capabilities, and auto-validation, which result in increased productivity and shorter turnaround times. Moreover, the continuous purchase of reagents and consumables, an increase in the number of tests due to the rising prevalence of blood-related diseases, and the incorporation of artificial intelligence-based decision-making systems are contributing to market growth.</p>
<div class="lb-trans"><p>每個產品和服務細分市場進一步包括儀器、試劑、耗材和服務。推動血液產品和服務細分市場在預測期內增長的主要因素包括實驗室自動化偏好的增加，如基於軌道的系統、中間件功能和自動驗證，這些都提高了生產力並縮短了週轉時間。此外，試劑和耗材的持續採購、由於血液相關疾病的流行而增加的測試數量，以及基於人工智能的決策系統的引入都在推動市場增長。</p>
</div><p><strong>Request Sample Pages@</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>請求樣本頁面 @</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
</div><p><strong>The blood cancer segment is projected to account for the largest share of hematology analyzers and reagents during the forecast period.</strong></p>
<div class="lb-trans"><p><strong>血液癌症細分市場預計將在預測期內佔據血液學分析儀和試劑的最大份額。</strong></p>
</div><p>In the application segment, blood cancer currently dominates the hematology analyzers and reagents market due to the high dependence on routine, highly accurate blood tests. Leukemia, lymphomas, myelomas, and other hematological cancers require regular measurement of cell counts and differentials, as well as assessment of abnormal cells, resulting in a sustained high number of tests. Early diagnosis and monitoring of diseases also largely depend on more sophisticated techniques for hematology testing and parameters. The increasing prevalence rates of hematological cancers all over the world will only solidify their position in the market.</p>
<div class="lb-trans"><p>在應用細分市場中，血液癌症目前主導血液學分析儀和試劑市場，因為高度依賴常規的高精度血液測試。白血病、淋巴瘤、骨髓瘤和其他血液腫瘤需要定期測量細胞計數和分類，以及評估異常細胞，從而導致持續的高測試數量。早期診斷和疾病監測在很大程度上也依賴於更復雜的血液學測試技術和參數。全球血液癌症的發病率不斷上升將進一步鞏固其在市場中的地位。</p>
</div><p><strong>Asia Pacific is projected to register the highest CAGR in the market during the forecast period.</strong></p>
<div class="lb-trans"><p><strong>亞太地區預計將在預測期內註冊市場最高的年均增長率。</strong></p>
</div><p>In 2025, Asia Pacific is projected to register the highest CAGR in the market for hematology analyzers and reagents during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. An increase in the incidence of infectious and chronic diseases, along with a growing number of patients, will drive demand for diagnostic tests. Other important factors likely to contribute to the growth of the market include increased availability of health services, growth of private diagnostic labs, use of efficient and economical analyzers, and heightened awareness of early disease detection. Moreover, advances in technology, such as portable and point-of-care (POC) hematology analyzers for resource-limited environments, will further fuel market growth.</p>
<div class="lb-trans"><p>在 2025 年，亞太地區預計將在血液學分析儀和試劑市場中註冊最高的年均增長率。亞太地區包括中國、印度、韓國、台灣和新加坡，以及亞太地區的其他國家。傳染病和慢性疾病的發生率增加，加上患者數量的增長，將推動對診斷測試的需求。其他可能促進市場增長的重要因素包括健康服務的可用性增加、私營診斷實驗室的增長、使用高效和經濟的分析儀，以及對早期疾病檢測的認識提高。此外，技術的進步，如適用於資源有限環境的便攜式和即時檢測（POC）血液學分析儀，將進一步推動市場增長。</p>
</div><p><strong>Inquire Before Buying@</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>購買前諮詢 @</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
</div><p><strong>Top Companies in Hematology Analyzers and Reagents Market:</strong></p>
<div class="lb-trans"><p><strong>血液學分析儀和試劑市場的頂級公司：</strong></p>
</div><p>The Top Companies in Hematology Analyzers and Reagents Market include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.</p>
<div class="lb-trans"><p>血液學分析儀和試劑市場的頂級公司包括 Sysmex Corporation（日本）、Danaher Corporation（美國）、Nihon Kohden Corporation（日本）、Siemens Healthineers（德國）、Abbott Laboratories（美國）、Boule Diagnostics AB（瑞典）、Horiba, Ltd.（日本）、Bio-Rad Laboratories Inc.（美國）、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（中國）和 F. Hoffmann-La Roche Ltd.（瑞士）等。</p>
</div><p><strong>Browse Adjacent Markets</strong>: <strong>Medical Devices Market Research</strong> <strong>Reports &amp; Consulting</strong></p>
<div class="lb-trans"><p><strong>瀏覽相關市場</strong>：<strong>醫療設備市場研究</strong> <strong>報告與諮詢</strong></p>
</div><p><strong>Related Reports:</strong></p>
<div class="lb-trans"><p><strong>相關報告：</strong></p>
</div><p><strong>In Vitro Diagnostics Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>體外診斷市場</strong> <strong>- 全球預測到 2030 年</strong></p>
</div><p><strong>Point of Care Diagnostics Market</strong> <strong>- Global Forecast to 2029</strong></p>
<div class="lb-trans"><p><strong>即時檢測市場</strong> <strong>- 全球預測到 2029 年</strong></p>
</div><p><strong>Coagulation Analyzer Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>凝血分析儀市場</strong> <strong>- 全球預測到 2030 年</strong></p>
</div><p><strong>Clinical Chemistry Analyzers Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>臨牀化學分析儀市場</strong> <strong>- 全球預測到 2030 年</strong></p>
</div><p><strong>IVD Reagents Market</strong> <strong>- Global Forecast to 2029</strong></p>
<div class="lb-trans"><p><strong>IVD 試劑市場</strong> <strong>- 全球預測到 2029 年</strong></p>
</div><p><strong>About MarketsandMarkets™</strong></p>
<div class="lb-trans"><p><strong>關於 MarketsandMarkets™</strong></p>
</div><p>MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.</p>
<div class="lb-trans"><p>MarketsandMarkets™被《福布斯》評選為美國最佳管理諮詢公司之一，依據其最新報告。</p>
</div><p>MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.</p>
<div class="lb-trans"><p>MarketsandMarkets™ 是增長諮詢和項目管理領域的藍海替代方案，利用人機結合的服務推動 B2B 領域進步組織的超常增長。我們以最廣泛的視角關注新興技術，擅長為全球客户共同創造超常增長。</p>
</div><p>Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.</p>
<div class="lb-trans"><p>如今，80% 的財富 2000 強公司依賴於 MarketsandMarkets，且每個行業前 100 家公司中有 90 家信任我們以加速其收入增長。我們擁有超過 13,000 家組織的全球客户羣，幫助企業在顛覆性生態系統中蓬勃發展。</p>
</div><p>The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.</p>
<div class="lb-trans"><p>B2B 經濟正在見證 25 萬億美元新收入來源的出現，這些收入將在本十年內取代現有的收入來源。我們與客户合作開展增長項目，幫助他們通過我們的服務線——市場總量擴展、市場進入（GTM）戰略到執行、市場份額提升、客户賦能和思想領導力營銷，來實現這一 25 萬億美元的機會。</p>
</div><p>Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.</p>
<div class="lb-trans"><p>基於 “GIVE Growth” 原則，我們與多家《福布斯》全球 2000 強 B2B 公司合作，幫助他們保持未來準備。我們的洞察和戰略由行業專家、尖端人工智能和我們的市場情報雲平台 KnowledgeStore™提供支持，整合研究並提供生態系統範圍內的收入變化可視化。</p>
</div><p>MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.</p>
<div class="lb-trans"><p>MarketsandMarkets™ SalesPlay 是一款基於人工智能的收入智能助手，旨在幫助收入團隊優先處理合適的客户，及早識別關鍵變化，並在需求之前發現機會，從而自然構建銷售管道，並以更高的一致性完成交易。</p>
</div><p>To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.</p>
<div class="lb-trans"><p>欲瞭解更多信息，請訪問 www.MarketsandMarkets™.com 或在 Twitter、LinkedIn 和 Facebook 上關注我們。</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>聯繫方式：</p>
</div><p>Mr. Rohan Salgarkar</p>
<div class="lb-trans"><p>羅漢·薩爾加卡爾（Mr. Rohan Salgarkar）</p>
</div><p>MarketsandMarkets™ INC.</p>
<div class="lb-trans"><p>MarketsandMarkets™ INC.</p>
</div><p>1615 South Congress Ave.</p>
<div class="lb-trans"><p>南國會大街 1615 號（1615 South Congress Ave.）</p>
</div><p>Suite 103, Delray Beach, FL 33445</p>
<div class="lb-trans"><p>103 套房，德爾雷海灘，佛羅里達州 33445（Suite 103, Delray Beach, FL 33445）</p>
</div><p>USA: +1-888-600-6441</p>
<div class="lb-trans"><p>美國電話：+1-888-600-6441</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>Visit Our Website: https://www.marketsandmarkets.com/</p>
<div class="lb-trans"><p>訪問我們的網站：https://www.marketsandmarkets.com/</p>
</div><p>Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
<div class="lb-trans"><p>標誌：https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
</div><p>SOURCE MarketsandMarkets</p>
<div class="lb-trans"><p>來源 MarketsandMarkets</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=IO57260&amp;Transmission_Id=202605121015PR_NEWS_USPR_____IO57260&amp;DateId=20260512"/></p>

ETHematology 分析儀和試劑市場預計到 2031 年將達到 103.3 億美元 | MarketsandMarkets™